BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

749 related articles for article (PubMed ID: 28780930)

  • 21. Integrative cancer pharmacogenomics to establish drug mechanism of action: drug repurposing.
    El-Hachem N; Ba-Alawi W; Smith I; Mer AS; Haibe-Kains B
    Pharmacogenomics; 2017 Nov; 18(16):1469-1472. PubMed ID: 29057710
    [No Abstract]   [Full Text] [Related]  

  • 22. Targeted immunotherapies overtaking emerging oncology market value based growth.
    Jakovljevic MB
    J BUON; 2015; 20(1):350-1. PubMed ID: 25778340
    [No Abstract]   [Full Text] [Related]  

  • 23. Repurposing drugs in your medicine cabinet: untapped opportunities for cancer therapy?
    Pantziarka P; Bouche G; Meheus L; Sukhatme V; Sukhatme VP
    Future Oncol; 2015; 11(2):181-4. PubMed ID: 25591833
    [No Abstract]   [Full Text] [Related]  

  • 24. Overcoming cancer therapeutic bottleneck by drug repurposing.
    Zhang Z; Zhou L; Xie N; Nice EC; Zhang T; Cui Y; Huang C
    Signal Transduct Target Ther; 2020 Jul; 5(1):113. PubMed ID: 32616710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug Repurposing in Anticancer Reagent Development.
    Chen PC; Liu X; Lin Y
    Comb Chem High Throughput Screen; 2017; 20(5):395-402. PubMed ID: 28025934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Old wine in new bottles: Drug repurposing in oncology.
    Antoszczak M; Markowska A; Markowska J; HuczyƄski A
    Eur J Pharmacol; 2020 Jan; 866():172784. PubMed ID: 31730760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repurposing medicinal compounds for blood cancer treatment.
    McCabe B; Liberante F; Mills KI
    Ann Hematol; 2015 Aug; 94(8):1267-76. PubMed ID: 26048243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How can attrition rates be reduced in cancer drug discovery?
    Moreno L; Pearson AD
    Expert Opin Drug Discov; 2013 Apr; 8(4):363-8. PubMed ID: 23373702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An update on Drug Repurposing: Re-written saga of the drug's fate.
    Gns HS; Gr S; Murahari M; Krishnamurthy M
    Biomed Pharmacother; 2019 Feb; 110():700-716. PubMed ID: 30553197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Keynote comment: Cancer drug pricing in the USA.
    Johnson DH
    Lancet Oncol; 2006 Jun; 7(6):444-5. PubMed ID: 16750490
    [No Abstract]   [Full Text] [Related]  

  • 32. Can Drug Repurposing Accelerate Precision Oncology?
    Schipper LJ; Zeverijn LJ; Garnett MJ; Voest EE
    Cancer Discov; 2022 Jul; 12(7):1634-1641. PubMed ID: 35642948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repurposing psychiatric drugs as anti-cancer agents.
    Huang J; Zhao D; Liu Z; Liu F
    Cancer Lett; 2018 Apr; 419():257-265. PubMed ID: 29414306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach.
    Advani D; Gupta R; Tripathi R; Sharma S; Ambasta RK; Kumar P
    Neurochem Int; 2020 Nov; 140():104841. PubMed ID: 32853752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug rechanneling: A novel paradigm for cancer treatment.
    Kaushik I; Ramachandran S; Prasad S; Srivastava SK
    Semin Cancer Biol; 2021 Jan; 68():279-290. PubMed ID: 32437876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Special issue: Drug repurposing for cancer therapy.
    Srivastava SK
    Semin Cancer Biol; 2021 Jan; 68():1-2. PubMed ID: 32679189
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug repurposing in oncology--patient and health systems opportunities.
    Bertolini F; Sukhatme VP; Bouche G
    Nat Rev Clin Oncol; 2015 Dec; 12(12):732-42. PubMed ID: 26483297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics.
    Kirtonia A; Gala K; Fernandes SG; Pandya G; Pandey AK; Sethi G; Khattar E; Garg M
    Semin Cancer Biol; 2021 Jan; 68():258-278. PubMed ID: 32380233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks.
    Strittmatter SM
    Nat Med; 2014 Jun; 20(6):590-1. PubMed ID: 24901567
    [No Abstract]   [Full Text] [Related]  

  • 40. Deal-making trends in oncology.
    Moore K; Walker J
    Nat Rev Drug Discov; 2009 Aug; 8(8):604. PubMed ID: 19644466
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.